Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.43SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDPSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.2.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LU.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.16.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
ML.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MM.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.1.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.86.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.58.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JH.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDD.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KR.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MD.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used